OMDA Omada Health
USHealthcareAs of 2026-07-09 16:00
Why OMDA matters now
Omada Health (OMDA) is a US stock in Healthcare. The latest InvestLog snapshot shows $23.55 with +2.48% on the session and $1.40B in market capitalization; recent performance reads 1-month +6.27% and YTD +11.79%.
The latest financial table shown here is Q1 2026, with revenue of $78.0M, net income of $-3.0M, and EPS of $-0.05. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.0%.
The latest indexable market news headline is "Omada Health, Inc. (OMDA) Is Up 7.18% in One Week: What You Should Know" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $22.00; recent insider activity includes Duffy Sean P. filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.44
P/S
3.70
EV/EBITDA
1704.49
DCF Value
$-64.20
FCF Yield
2.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
66.2%
Operating Margin
-2.9%
Net Margin
-2.2%
ROE
-2.8%
ROA
-2.1%
ROIC
-3.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $78.0M | $-3.0M | $-0.05 |
| Q4 2025 | $75.8M | $5.2M | $0.09 |
| FY 2025 | $260.2M | $-12.8M | $-0.22 |
| Q3 2025 | $68.0M | $-3.2M | $-0.05 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$22.00
Target (Median)
$22.00
Target Range
$18.00 - $26.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
2.09
Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.